Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 813 results for "herceptin"

Amgen, Allergan biosimilar found as effective as Roche cancer drug
Channel NewsAsia

Amgen, Allergan get biosimilar lift with positive data on Herc...

Dive Brief: Amgen and Allergan said Thursday a Phase 3 trial of their biosimilar version of Roche's cancer drug Herceptin showedare no 'clinically meaningful differences' between the two medicines. One of Roche's mainstay biologic drugs, ... BioPharma Dive, 1 day ago

29 images for herceptin

Bidness Etc, 1 day ago, 2 days ago
FierceBiotech, 3 days ago
Pharmafile, 1 day ago
Fortune, 1 month ago
Nasdaq, 1 month ago
BioSpace, 1 month ago, 1 month ago, 2 months ago, 2 months ago

Late-stage study shows biosimilar candidate ABP 980 non-inferior to Roche's Herceptin

Results from a randomized 725-subject Phase 3 study assessing the safety and efficacy of Amgen ( AMGN +0.4%) and collaboration partner Allergan's ( AGN +0.5%) biosimilar candidate ABP 980 compared with Roche's ( OTCQX:RHHBY ) Herceptin (trastuzumab) ...
 Seeking Alpha2 days ago Phase III study confirms similarity of Herceptin biosimilar from Amgen, Allergan  Pharmafile1 day ago Proposed biosimilar ABP 980 appears comparable to Herceptin for HER-2positive breast cancer  Healio1 day ago Study finds Amgen, Allergan's proposed biosimilar ABP 980 comparable to Roche's Herceptin  FirstWord Pharma2 days ago

Cause of heart side effects of breast cancer drug Herceptin revealed

Visualization of the coronary vasculature patterningof an adult mouse heart. --Courtesy of Haig Aghajanian,Perelman School of Medicine at the University of Pennsylvania and Young Kuk Cho One of the known side effects of the breast cancer drug ...
 FierceBiotech3 days ago Preclinical study outlines cardiovascular side effects of breast cancer drug  Science Daily5 days ago Understanding the Cardiovascular Side Effects of Breast Cancer Drug 'Trastuzumab'  MedIndia1 week ago Cardiovascular side effects of trastuzumab for breast cancer  Ecancer Medicalscience1 week ago

Second Herceptin Biosimilar Passes Test in Breast Cancer Subset

Another biosimilar for Herceptin proved to have similar outcomes as the original drug for patients with breast cancer in a phase 3 trial. A phase 3 study involving patients with HER2-positive early breast cancer demonstrated that the biosimilar ABP ...
 CURE Magazine1 day ago NHS 'will face court if Abi Longfellow's life-saving drugs are delayed any longer'  NewsFlow242 weeks ago Mylan biosimilar as good as Herceptin in advanced breast cancer, study reveals  Pharma Letter1 month ago BIOCON UPBEAT ON NEW CANCER DRUG TO TAP $7-BILLION MARKET  Pharmacy Choice1 month ago

High Court order not to affect product portfolio, says Biocon

Delhi High Court had prevented Biocon from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin.
 DNA2 months ago HC order not to impact product portfolio, says Biocon  Money Control2 months ago

Amgen and Allergan Report Progress in Herceptin® Biosimilar Clinical Trial

In the late 1980's, Dennis Slamon discovered a new oncogene, Her2/neu,that was amplified in 25-33% of human breast cancers. Slamon et al., "," Science 244: 707-12 (1989). Following up on this discovery, Dr. Slamon and his collaborators found that a ...
 JD Supra1 day ago Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin  4 Traders2 days ago
Bidness Etc

Amgen, Allergan May Bring First Herceptin Biosimilar to US Market

The first biosimilar to a major cancer treatment is one step closer to the US market. Amgen, Inc. (NASDAQ:AMGN) and Allergan Plc. (NYSE:AGN) announced on Thursday that their biosimilar version of Roche Holding's breast cancer drug, Herceptin was ...
 Mr Top Step1 day ago Amgen Offers 50% Upside From Current Prices  Seeking Alpha1 month ago
India Infoline

Delhi HC allows Biocon, Mylan to continue sale of Cancer drugs

Justice Manmohan Singh made it clear that these companies would not call their product "bio similar" to 'Herceptin, Herclon, Biceltis', the brand names of products by firm Roche Products (India) Pvt Ltd. The Delhi High Court has allowed Biocon Ltd and Mylan ...
 India Infoline2 months ago

ViewPoints: The race to develop biosimilar Herceptin hots up

You attempted to read ViewPoints , exclusive content for FirstWord Pharma PLUS members. You currently are not registered for any FirstWord Pharma services. To gain instant access to ViewPoints plus additional enhanced content and features, please ...
 FirstWord Pharma1 day ago
Business Insider

Lawyers for Roche, Biocon trade contempt charges in Herceptin biosim case

A long-running court case filed in India by Roche ($RHBBY) seeking to prevent the use of label language by Bangalore-based Biocon and Mylan ($MYL) from claiming similarity to its aging breast cancer medHerceptin (trastuzumab) has turned tense--with ...
 FiercePharma5 days ago Russia Drug Maker Accuses Roche of Sabotaging Biosimilars  Converter News4 weeks ago Roche, Biocon clash accusing contempt of court  Economic Times1 week ago A Russian drug company is accusing Roche of sabotaging biosimilar competition  Business Insider4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - herceptin
Get updated on latest news & your favorite topics right in your inbox!
More     Less